Recent developments in pediatric acute respiratory distress syndrome therapy;Les developpements recents dans le traitement du syndrome de detresse respiratoire aigu en pediatrie

Archives de Pediatrie

Volumn 5, Issue 10, 1998, Pages 1107-1021

  Fraisse, A ^a   Paut, O ^a   Viard, L ^a   Camboulives, J ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Acute respiratory distress syndrome; Child; Pathophysiology; Treatment

Indexed keywords

ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; LUNG SURFACTANT; NITRIC OXIDE; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR; VASODILATOR AGENT;

ACUTE DISEASE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY VENTILATION; HUMAN; HYPERCAPNIA; IATROGENIC DISEASE; JET VENTILATION; LUNG INJURY; MORTALITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY DISTRESS SYNDROME; REVIEW; THORAX RADIOGRAPHY; TIDAL VOLUME; ADULT RESPIRATORY DISTRESS SYNDROME; BREATHING MECHANICS; CHILD; MORBIDITY;

CHILD; HUMANS; MORBIDITY; POSITIVE-PRESSURE RESPIRATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MECHANICS;

EID: 0032185804     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(99)80009-8     Document Type: Article

References (90)

1. 1 Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967 ; ii : 319-23
2. 2 Royall JA, Levin DL. Adult respiratory distress syndrome in pediatric patients. J Pediatr 1988 ; 112 : 169-80
3. 3 Rayet I, Blanc PL, Holzapfel L, Robert D. Le syndrome de détresse respiratoire de « type adulte » en pédiatrie. Arch Fr Pédiatr 1986 ; 43 : 29-34
4. 4 Pfenninger J, Tschaeppeler H, Wagner BP, Weber J, Zimmerman A. The paradox of adult respiratory distress syndrome in neonates. Pediatr Pulmonol 1991 ; 10 : 18-24
5. 5 The American-European Consensus Conference on ARDS. Am J Respir Care Med 1994 ; 149 : 818-24
6. 6 Tomashefsky JF. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990 ; 11 : 593-619
7. 7 Fowler AA, Hammam RF, Zerbe GO, Benson KN, Hyers TM. Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis 1985 ; 132 : 472-8
8. 8 DeBruin W, Notterman DA, Magid M, Godwin T, Johnston S. Acute hypoxemic respiratory failure in infants and children: clinical and pathologic characteristics. Crit Care Med 1992 ; 20 : 1223-34
9. 9 Holm BA, Notter RH, Siegle J, Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985 ; 59 : 1402-9
10. 10 Northway WH Jr. Observations on bronchopulmonary dysplasia. J Pediatr 1979 ; 95 : 815-8
11. 11 Barnes ND, Glover WJ, Hull D, Milner AD. Effect of prolonged positive-pressure ventilation in infancy. Lancet 1969 ; ii : 1096-9
12. 12 Heulitt MJ, Anders M, Benham D. Acute respiratory distress syndrome in pediatric patients: redirecting therapy to reduce iatrogenic lung injury. Respir Care 1995 ; 40 : 74-85
13. 13 Dreyfuss D, Soler P, Saumon G. Spontaneous resolution of pulmonary edema caused by shorted period of cyclic overinflation. J Appl Physiol 1992 ; 72 : 2081-9
14. 14 Borelli M, Kobolow T, Spatola R, Prato P, Tsuno K. Severe acute respiratory failure managed with continuous positive airway pressure and partial extracorporeal carbon dioxide removal by an artificial membrane lung: a controled, randomized animal study. Am Rev Respir Dis 1988 ; 138 : 1480-7
15. 15 Dreyfuss D, Basset G, Soler P, Saumon G. Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 1985 ; 132 : 880-4
16. 16 Parker JC, Hernandez LA, Longenecker GL, Peevy K, Johnson W. Lung edema caused by high inspiratory pressures in dogs: role of increased microvascular filtration pressure and permeability. Am Rev Respir Dis 1990 ; 142 : 321-8
17. 17 Greenfield LJ, Ebert PA, Benson DW. Effect of positive pressure ventilation on surface tension properties of lung extracts. Anesthesiology 1964 ; 25 : 313-7
18. 18 Bowton DL, Kong DL. High tidal volume ventilation produces increased lung water in oleic acid-injured rabbit lungs. Crit Care Med 1989 ; 17 : 908-11
19. 19 Goodman BE, Wangensteen D. Alveolar epithelium permeability to small solutes: developmental changes. J Appl Physiol 1982 ; 52 : 3-8
20. 20 Muller NL, Bryan AC. Chest wall mechanics and respiratory muscles in infants. Pediatr Clin North Am 1979 ; 26 : 503-16
21. 21 Paulson TE, Spear RM, Peterson BM. New concepts in the treatment of chidren with acute respiratory distress syndrome. J Pediatr 1995 ; 127 : 163-75
22. 22 Durand P, Le Pommelet C, Orbach D, Devictor D, Huault G. Aspects actuels du syndrome de détresse respiratoire aigu de l'enfant. Arch Fr Pédiatr 1997 ; 4 : 61-77
23. 23 Zaccardelli DS, Pharm D, Pattishall EN. Clinical diagnostic criteria of the adult respiratory distress syndrome in the intensive care unit. Crit Care Med 1996 ; 24 : 247-51
24. 24 Rivera RA, Butt W, Shann F. Predictors of mortality in children with respiratory failure: possible indication for ECMO. Anaesth Intensive Care 1990 ; 18 : 385-9
25. 25 Tamburro RF, Bugnitz MC, Stidham GL. Alveolar arterial oxygen gradient as a predictor of outcome for patients with non-neonatal respiratory failure. J Pediatr 1991 ; 119 : 935-8
26. 26 Murray JF, Matthay MA, Luce JM. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988 ; 138 : 720-3
27. 27 Lain DC, DiBenedetto R, Morris SL, Nguyen AV, Saulters R, Causey D. Pressure control inverse ratio ventilation as a method to reduce peak inspiratory pressure and provide adequate ventilation and oxygenation. Chest 1989 ; 95 : 1081-8
28. 28 Boros S. Variations of I/E ratio and airway pressure wave form during mechanical ventilation: the significance of mean airway pressure. J Pediatr 1979 ; 94 : 114-7
29. 29 Al-Saady N, Bennett ED. Decelerating inspiratory flow waveform improves lung mechanics and gas exchange in patients on intermittent positive pressure ventilation. Intensive Care Med 1985 ; 11 : 68-75
30. 30 Suter PM, Fairley HB, Isenberg MD. Effect of tidal volume and PEP on compliance during mechanical ventilation. Chest 1978 ; 73 : 158-62
31. 31 Kolobow T, Moretti MP, Fumagalli R, Mascheroni D, Prato P, Chen V et al. Severe impairment in lung function induced by hight peak airway pressure during mechanical ventilation. Am Rev Respir Dis 1987 ; 135 : 312-5
32. 32 Argiras EP, Blakeley CR, Dunnhill S, Otremski S, Sykes MK. High PEEP decreases hyaline membrane disease in surfactant deficient lungs. Br J Anaesth 1987 ; 59 : 1278-85
33. 33 Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia. Crit Care Med 1994 ; 22 : 1568-78
34. 34 Rosenberg RB, Anglin DL. Mechanical ventilation of children with the adult respiratory distress syndrome. Pediatr Pulmonol 1995 ; 11 : 108-9
35. 35 Gattinoni L, Pelosi P, Vitale G, Pesenti A, D'Andrea L, Mascheroni D. Body position changes redistribute lung computed tomographic density in patients with acute respiratory failure. Anesthesiology 1991 ; 74 : 15-23
36. 36 Chatte G, Sab JM, Dubois JM, Sirodot M, Gossorgues P, Robert D. Prone position in mecanically ventilated patients with severe acute respiratory failure. Am J Respir Crit Care Med 1997 ; 155 : 473-8
37. 37 Sjöstrand U. Review of the physiological rationale for and development of high-frequency positive pressure ventilation -HFPPV. Acta Physiol Scand 1967 ; 64 Suppl : 7-27
38. 38 Jonzon A, Öberg PA, Sedin G, Sjöstrand U. High-frequency low tidal volume positive pressure ventilation. Acta Physiol Scand 1970 ; 80 : 21A
39. 39 Paulson TE, Spear RM, Petreson BM. Improved survival using high-frequency pressure control ventilation with high PEP in children with ARDS. Crit Care Med 1993 ; 21 : S290
40. 40 Sanders RD. Two ventilating attachments for bronchoscopes. Del Med J 1967 ; 39 : 170-6
41. 41 Klain M, Smith B. High-frequency percutaneous transtracheal jet ventilation. Crit Care Med 1977 ; 5 : 280-7
42. 42 Borg UR, Stoklosa JC, Siegel JH, Wiles CE, Belzberg H, Blevins S et al. Prospective evaluation of combined high-frequency ventilation in post-traumatic patients with adult respiratory distress syndrome refractory to optimized conventional ventilatory management. Crit Care Med 1989 ; 33 : 145-8
43. 43 Smith DW, Frankel LR, Derish MT, Moody RR, Black LE 3d, Chipps BE et al. High-frequency jet ventilation in children with the adult respiratory distress syndrome complicated by pulmonary barotrauma. Pediatr Pulmonol 1993 ; 15 : 279-86
44. 44 Lunkenheimer PP, Rafflenbeul W, Keller H, Franck I, Dickhut HH, Fuhrman C. Application of transtracheal pressure oscillation as a modification of diffusion respiration. Br J Anaesth 1972 ; 44 : 627-35
45. 45 Rehder K, Schmidt ER, Knopp TJ. Long-term high-frequency ventilation in dogs. Am Rev Respir Dis 1983 ; 128 : 476-80
46. 46 Arnold JH, Truog RD, Thompson JE, fackler JC. High-frequency oscillatory ventilation in pediatric respiratory failure. Crit Care Med 1993 ; 21 : 272-8
47. 47 Arnold GH, Hanson JH, Toro-figuero LO, Gutierrez J, Berens RJ, Anglin DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994 ; 22 : 1530-9
48. 48 Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993 ; 328 : 399-405
49. 49 Rossaint R, Schmidt-Ruhnke A, Steudel W, Pappert D, Kaiser U, Falke K. Retrospective analysis of survival in patients with severe acute respiratory distress syndrome treated with and without nitric oxide innhalation [abstract]. In: Society of Critical Care Medicine's 24th Educational and Scientific Symposium, San Francisco, 1995. Crit Care Med 1995 ; 23 : 112
50. 50 Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effect of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994 ; 124 : 881-8
51. 51 Demirakça S, Dötsch J, Knothe C, Magsaam J, Reiter HL, Bauer J et al. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation and weaning. Crit Care Med 1996 ; 24 : 1913-9
52. 52 The neonatal Inhaled Nitric Oxide Group. Inhaled nitric oxid in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997 ; 336 : 597-604
53. 53 Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at athmospheric pressure. Science 1966 ; 152 : 1755-6
54. 54 Tütüncü AS, Faithfull NS, Lachman B. Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dose dependent improvement in gas exchange. Crit Care Med 1993 ; 21 : 962-9
55. 55 Wolfson MR, Greenspan JS, Shaffer TH. Pulmonary administration of vasoactive substances by perfluorochemical ventilation. Pediatrics 1996 ; 97 : 449-55
56. 56 Houmes RJM, Hartog A, Verbrugge SJC, Böhm S, Lachmann B. Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury. Intensive Care Med 1997 ; 23 : 163-9
57. 57 Gauger PG, Pranikoff T, Schreiner RJ, Moler FW, Hirschl RB. Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med 1996 ; 24 : 16-22
58. 58 Hurst JM, Branson RD. Liquid breathing-partial liquid ventilation. Respir Care 1996 ; 41 : 416-22
59. 59 Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 1996 ; 335 : 761-7
60. 60 Conrad SA, Bagley A, Bagley B, Schaap RN. Major findings from the clinical trials of the intravascular oxygenator. Artif Organs 1994 ; 18 : 846-63
61. 61 Ortiz RM, Cilley RE, Bartlett RH. ECMO in Pediatric respiratory failure. Pediatr Clin North Am 1987 ; 34 : 39-46
62. 62 Morton A, Dalton H, Kochanek P, Janotsky J, Thompson A. Extracorporeal membrane oxygenation for Pediatric respiratory failure: five-year experience at the university of Pittsburg. Crit Care Med 1994 ; 22 : 1659-67
63. 63 Weber TR, Tracy TF, Connors R, Kountzman B, Pennington DG. Prolonged for noneonatal respiratory failure. J Pediatr Surg 1992 ; 27 : 1100-5
64. 64 O'Rourke PP, Stolar CJH, Zwischenberger JB, Snedecor S, Bartlett R. Extracorporeal membrane oxygenation: support for overwhelming pulmonary failure in the pediatric population-collective experience from the Extracorporeal Life Support Organization. J Pediatr Surg 1993 ; 28 : 523-9
65. 65 Wilson BG. Extracorporeal and intracorporeal techniques for the treatment of severe respiratory failure. Respir Care 1996 ; 41 : 306-17
66. 66 Gattinoni L, Pesenti A, Bombino M, Pelosi P, Brazzi L. Role of extracorporeal circulation in adult respiratory distress syndrome management. New Horiz 1993 ; 1 : 603-12
67. 67 Zupan V, Lacaze-Masmonteil T. Le surfactant pulmonaire : de la physiopathologic à la thérapeutique. Méd Sci 1993 ; 9 : 277-87
68. 68 Pison U, Obertacke U, Brand M, Seeger W, Joka T, Bruch J et al. Altered pulmonary surfactant in uncomplicated and septicemia complicated courses of acute respiratory failure. J Trauma 1990 ; 30 : 19-26
69. 69 Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, Egan EA A controlled comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992 ; 145 : 999-1004
70. 70 Spragg RG, Gilliard N, Richman P, Smith RM, Hite RD, Pappert D et al. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994 ; 105 : 195-202
71. 71 Pramanik AK, Holtzman RB, Merritt TA. Surfactant replacement therapy for pulmonary diseases. Pediatr Clin North Am 1993 ; 40 : 913-36
72. 72 Heikinheimo M, Hynynen M, Rautiainen P, Andersson S, Hallman M, Kukkonen S. Successful treatment of ARDS with two doses of synthetic surfactant. Chest 1994 ; 105 : 1263-4
73. 73 Fraisse A, Paul O, Silicani MA, Viard L, Camboulives J. Intérêt du surfactant exogène dans le traitement du SDRA de l'enfant : une nouvelle observation. Arch Fr Pédiatr 1996 ; 3 : 891-5
74. 74 Weg JG, Balk RA, Tharratt S, Jenkinson SG, Shah JB, Zaccardelli D et al. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 1994 ; 272 : 1433-8
75. 75 Wiedemann H, Baughman R, de Boisblanc B, Schuster D, Caldwell E, Weg J et al. A multicenter trial in human sepsis-induced ARDS of an aerosolized synthetic surfactant (Exosurf). Am Rev Respir Dis 1992 ; 145 : A184
76. 76 Zelter M, Escudier BJ, Hoeffel JM, Murray JF. Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis 1990 ; 141 : 1014-9
77. 77 Anzueto A, Baughman R, Guntupalli K, DeMaria E, Davis K, Weg J et al. The exosurf ARDS Sepsis study Group. An international randomized, placebo-controlled trial evaluating the safety and efficacy of aerosolized surfactant in patients with sepsis-induced ARDS. Am J Respir Crit Care Med 1994 ; 149 : A567
78. 78 Segerer H, Van Gelder W, Angenent FWM, Van Woerkens LJPM, Curstedt T, Obladeen M et al. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbit are influenced by instillation technique. Pediatr Res 1993 ; 34 : 490-4
79. 79 Segerer H, Scheid A, Wagner M, Obladen M. Tracheal surfactant infusion during 5 minutes is less effective than bolus instillation in rabbits. Pediatr Res 1994 ; 36 : 37A
80. 80 Gregory TJ, Longmore WJ, Moxely MA, Cai GZ, Gadek JE, Weiland JE et al. Surfactant repletion following Survanta supplementation in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1994 ; 149 : A124
81. 81 Lewis T, Dhillon J, Frewen T. Exogenous surfactant therapy in pediatric patients with ARDS. Am J Respir Crit Care Med 1994 ; 149 : A125
82. 82 Haslam PL, Hughes DA, Mac Naughton PD, Baker CS, Evans TW. Surfactant replacement therapy in late stage adult respiratory distress syndrome. Lancet 1994 ; 343 : 1009-11
83. 83 Lewis J, Frewen T, Hutchinson J, Simons J, Splinter W, Kowesi T. Exogenous surfactant therapy for pediatric ARDS patients [abstract]. In: Pediatric Critical Care Colloquium, 1994
84. 84 Perez-Benavides F, Riff E, Franks C. Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient. Pediatr Emerg Care 1995 ; 11 : 153-5
85. 85 Willson DF, Jiao JH, Bauman LA, Zaritsky A, Craft H, Dockery K et al. Calf's lung surfactant extract in acute respiratory failure in children. Crit Care Med 1996 ; 24 : 1316-22
86. 86 Evans DA, Wilmott RW, Whitsett JA. Surfactant replacement therapy for adult respiratory distress syndrome in children. Pediatr Pulmonol 1996 ; 21 : 328-36
87. 87 Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987 ; 371 : 1565-70
88. 88 Meduri GH, Chinn AJ, Leeper KV, Wunderink RG. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Chest 1994 ; 105 : 1516-27
89. 89 Bone RC, Slotman G, Maunder R, Silverman H and the prostaglandin E1 Study Group. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Chest 1989 ; 96 : 114-9
90. 90 Walmrath D, Schneider T, Schermuly R, Olschewski H, Grimminger F, Seeger W. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996 ; 153 : 991-6